CD274 and cancer: Some probiotics, such as Bifidobacterium, Lactobacillus, Propionibacterium, and Streptococcus thermophilus, are effective in improving the prognosis of cancer patients when combined with monoclonal antibodies (PD-1/PD-L1, CTLA4) (Li et al., 2022).